Contact
Please use this form to send email to PR contact of this press release:
Process for Handling Referrals to FDA Under 21 CFR 50.54 - Additional Safeguards for Children in Clinical Investigations
TO:
Please use this form to send email to PR contact of this press release:
Process for Handling Referrals to FDA Under 21 CFR 50.54 - Additional Safeguards for Children in Clinical Investigations
TO: